Ads
related to: divalproex sodium brand name- Efficacy & Safety Info
Learn More About EPIDIOLEX®
Efficacy & Safety Info.
- Why EPIDIOLEX®
EPIDIOLEX® Is Designed With Your
Patients In Mind. Learn More.
- Efficacy & Safety Info
Search results
Results From The WOW.Com Content Network
Valproate (valproic acid, VPA, sodium valproate, and valproate semisodium forms) are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. [7] They are useful for the prevention of seizures in those with absence seizures , partial seizures , and generalized seizures . [ 7 ]
Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use ... divalproex sodium: Valproate: 181,554: 0.00%:
Depakote (valproic acid/sodium valproate) – an antiepileptic and mood stabilizer used to treat bipolar disorder, neuropathic pain and others; sometimes called an antimanic medication. Depakene is the trade name for the same drug prepared without sodium. Desyrel – an atypical antidepressant used to treat depression and insomnia
It will be sold under the brand name Journavx. The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Sodium valproate [note 1] Convulex, Depakene, Depakine Enteric, Orfiril, Stavzor Divalproex sodium [note 2] Depakote, Epival, Ergenyl Chrono Sodium valproate and valproic acid in 2.3:1 ratio: Depakine Chrono, Depakine Chronosphere, Epilim Chrono, Epilim Chronosphere
Esketamine, the chemical name for Spravato, is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname “Special K”.
It will be sold under the brand name Journavx. A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. ... “It is an important step ...
Valproic acid, and its derivatives such as sodium valproate and divalproex sodium, causes cognitive deficit in the child, with an increased dose causing decreased intelligence quotient and use is associated with adverse neurodevelopmental outcomes (cognitive and behavioral) in children.